semaglutide and kidney health Saving kidneys, hearts lives': Diabetes drug found to reduce risk of disease and death FLOWing with the SemagluTIDE —

The results were unambiguous: 28.3% average weight loss at 80 weeks in 2,339 adults without diabetes, meeting all primary and key secondary endpoints

Our clinical team reviews your complete hormonal and metabolic profile including IGF-1, insulin, fasting glucose, and metabolic panel and provides a physician-reviewed interpretation with clear next-step guidance

New York, NY

To determine your specific coverage, we recommend contacting your insurance provider directly

* You must have purchased our protection insurance

Kidney Problems: GLP-1 medications can sometimes affect kidney function, especially in people with pre-existing kidney disease